Related Experiment Video
Updated: Jul 4, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Potential Benefits and Risks of Interim Analyses in Clinical Studies
1Department of Biostatistics, Brown University, Providence, RI.
None:
Interim analyses are statistical evaluations of data collected during an ongoing study. These analyses can provide early evidence of the effectiveness and safety of an intervention, allowing investigators to make informed decisions about whether to continue the trial or revise the study design to optimize the trial outcomes. When used judiciously, interim analyses offer potential benefits such as resource and time savings, expedited treatment development, and protecting patients from ineffective or unsafe interventions.
More Related Videos
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Assumptions of Survival Analysis